desloratadine has been researched along with Sensitivity and Specificity in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Enany, N; El-Shaheny, RN; Ibrahim, FA; Mikhail, IE | 1 |
| Chen, G; Daaro, I; Piwinski, JJ; Pramanik, BN | 1 |
| Fan, G; Hong, Z; Wei, H; Wen, J; Wu, Y | 1 |
| Patel, BN; Sanyal, M; Sharma, N; Shrivastav, PS | 1 |
| Amad, M; Mylchreest, I; Rudewicz, PJ; Schoen, AE; Schweingruber, H; Winnik, WM; Yang, L | 1 |
| Beaudry, F; Clement, RP; Di Donato, L; Grandmaison, C; Kantesaria, B; Masse, R; Reyderman, L; Rudewicz, PJ; Yang, L | 1 |
| David, V; Medvedovici, A; Sora, DI; Udrescu, S | 1 |
| Clement, RP; Hayes, RN; Merka, EA; Shen, JX; Tama, CI; Xu, Y | 1 |
| Chen, WL; Chu, NN; Li, XN; Xu, HR | 1 |
| Bandaru, VV; Patel, RS; Rao, AA; Rao, MN; Shedbalkar, VP; Srinubabu, G | 1 |
| Christensen, J; Johnson, R; Lin, CC | 1 |
| Kreutner, W; Lichtenstein, LM; Schleimer, RP; Schroeder, JT | 1 |
1 trial(s) available for desloratadine and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC/MS/MS and its application to pharmacokinetics and bioequivalence.
Topics: Administration, Oral; Chromatography, Liquid; Cross-Over Studies; Drug Stability; Humans; Loratadine; Male; Reference Standards; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency | 2007 |
11 other study(ies) available for desloratadine and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous determination of desloratadine and montelukast sodium using second-derivative synchronous fluorescence spectrometry enhanced by an organized medium with applications to tablets and human plasma.
Topics: Acetates; Calibration; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Cyclopropanes; Humans; Hydrogen-Ion Concentration; Limit of Detection; Loratadine; Quinolines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Spectrometry, Fluorescence; Sulfides; Tablets | 2015 |
Structural characterization of in vitro rat liver microsomal metabolites of antihistamine desloratadine using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange HR-LC/MS.
Topics: Animals; Chromatography, Liquid; Cyclic N-Oxides; Histamine H1 Antagonists, Non-Sedating; Liver; Loratadine; Mass Spectrometry; Microsomes; Rats; Sensitivity and Specificity | 2009 |
Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.
Topics: Adult; Asian People; Calibration; Chromatography, Liquid; Cyproheptadine; Drug Stability; Female; Formates; Freezing; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Methanol; Molecular Structure; Platelet Activating Factor; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Time Factors; Water; Young Adult | 2009 |
LC-MS-ESI for the determination of loratadine and descarboethoxyloratadine in human plasma.
Topics: Chromatography, Liquid; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Piperidines; Pyridines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Time Factors | 2010 |
Investigation of an enhanced resolution triple quadrupole mass spectrometer for high-throughput liquid chromatography/tandem mass spectrometry assays.
Topics: Calibration; Chromatography, High Pressure Liquid; Loratadine; Mometasone Furoate; Pharmaceutical Preparations; Piperidines; Pregnadienediols; Pyridines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2002 |
Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma.
Topics: Automation; Calibration; Chromatography, Liquid; Humans; Loratadine; Mass Spectrometry; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Validated ion pair liquid chromatography/fluorescence detection method for assessing the variability of the loratadine metabolism occurring in bioequivalence studies.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Drug Stability; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Molecular Structure; Piperidines; Pyridines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Therapeutic Equivalency | 2007 |
Simultaneous determination of desloratadine and pseudoephedrine in human plasma using micro solid-phase extraction tips and aqueous normal-phase liquid chromatography/tandem mass spectrometry.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Complex Mixtures; Ephedrine; Humans; Loratadine; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction; Spectrometry, Mass, Electrospray Ionization | 2007 |
Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of loratadine and desloratadine in human plasma.
Topics: Chromatography, Liquid; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen-phosphorus detector.
Topics: Child; Chromatography, Gas; Female; Humans; Hydrogen-Ion Concentration; Loratadine; Male; Nitrogen; Phosphorus; Piperidines; Pyridines; Sensitivity and Specificity | 1994 |
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Topics: Basophils; Cell Culture Techniques; Cytokines; Dose-Response Relationship, Drug; Gene Expression; Histamine H1 Antagonists; Histamine Release; Humans; Immunoglobulin E; Inflammation Mediators; Interleukin-13; Interleukin-4; Leukotriene C4; Loratadine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity | 2001 |